Tag

Venture Capital

All articles tagged with #venture capital

Arielle Zuckerberg Confirms Years of Secret DJ Career After Viral Video Surfaces
entertainment2 days ago

Arielle Zuckerberg Confirms Years of Secret DJ Career After Viral Video Surfaces

Arielle Zuckerberg, the youngest sister of Meta CEO Mark Zuckerberg, has publicly confirmed that she has been a professional DJ since 2018. The revelation came after a video of her performing at San Francisco Tech Week circulated online. Arielle, who is also a venture capital partner, described her DJing as a 'side quest' and a way to spread joy, noting that she has performed at major events like Burning Man and various clubs.

Zeroset Raises $5.2M to Build Dynamic Operational Memory for Enterprise AI Agents
technology3 days ago

Zeroset Raises $5.2M to Build Dynamic Operational Memory for Enterprise AI Agents

Zeroset, a startup founded by two recent college dropouts, has emerged from stealth with a $5.2 million pre-seed round to develop 'Nebula,' a system that teaches AI agents how specific companies operate. The product connects to existing enterprise tools like Microsoft 365 and GitHub to track workflow sequences and decision histories, aiming to solve the problem of AI agents lacking context on proprietary business dynamics. The company, backed by Google’s Gradient fund, is currently in a closed research preview and plans to expand access gradually to enterprises in manufacturing, supply chain, and financial research sectors.

AI coding rivals Factory and Cognition clash over executive poaching
technology8 days ago

AI coding rivals Factory and Cognition clash over executive poaching

A public dispute has erupted between AI coding startups Factory and Cognition over the hiring of Chris Degnan, a former Factory board observer who joined Cognition as chief revenue officer. Factory CEO Matan Grinberg accused Cognition of unethical recruitment tactics, including faking interviews to gather confidential information, while Cognition CEO Scott Wu denied the claims. The conflict highlights intense competition in the AI coding market, where both companies recently secured massive funding rounds at valuations exceeding $40 billion. Industry figures have weighed in, with some condemning the breach of trust and others defending the move as standard business practice.

Beam Therapeutics sues former scientist over alleged IP theft for Chinese startup
biotechnology10 days ago

Beam Therapeutics sues former scientist over alleged IP theft for Chinese startup

Cambridge-based gene-editing firm Beam Therapeutics has filed a lawsuit alleging that former scientist Zi Jun 'Emma' Wang stole proprietary data to co-found a Shanghai-based company, YolTech Therapeutics. The suit claims Wang accessed electronic lab notebooks during off-hours to build the foundation for a new venture, Serapha Bio, which recently secured funding from venture capital firms RA Capital and RTW. This legal action highlights rising tensions between American biotech firms and Chinese counterparts, as Beam seeks to protect its intellectual property from alleged misappropriation.

A16z Launches $42M San Francisco Academy to Bypass Traditional College
technology-and-education16 days ago

A16z Launches $42M San Francisco Academy to Bypass Traditional College

Andreessen Horowitz has launched the Horowitz Andreessen Academy, a for-profit, unaccredited alternative to college in San Francisco. The program offers a tuition-free, one-year fellowship for 50 students, focusing on AI product development without traditional grades or homework. Backed by $42 million from major tech firms, the academy aims to train young entrepreneurs for the AI era, with a paid two-year program planned for 2028.

Tekever Reaches $6.4 Billion Valuation in Major Defense Tech Funding Round
technology16 days ago

Tekever Reaches $6.4 Billion Valuation in Major Defense Tech Funding Round

Portuguese-British AI drone maker Tekever has secured a $580 million funding round, valuing the company at $6.4 billion. The capital will support international expansion, industrial scaling, and strategic acquisitions. Tekever’s autonomous surveillance systems have logged over 50,000 flight hours in Ukraine since 2022, highlighting its operational relevance amid Europe’s rearmament efforts.

VC Funds, a House, and a Caribbean Wedding: Arrest Exposes Startup Fraud
business22 days ago

VC Funds, a House, and a Caribbean Wedding: Arrest Exposes Startup Fraud

Shiloh Luckey, founder of ComplYant, was arrested in Florida on nine counts of securities fraud, three counts of wire fraud, one count of bank fraud, and two counts of money laundering, accused of misrepresenting herself as a CPA and siphoning VC funds to buy a Los Angeles home, a car, and to finance a Caribbean wedding. The case follows a $5.5 million seed round in 2022 led by Craft Ventures, a separate SEC civil action accusing revenue misrepresentation, and Luckey’s startup shutdown; prosecutors say she used check-kiting and other schemes to cover shortfalls. She faces federal court in Los Angeles after being released on bond.

Family Offices Fuel Biotech Boom as AI Accelerates Drug Discovery
business1 month ago

Family Offices Fuel Biotech Boom as AI Accelerates Drug Discovery

In August, family offices completed 52 direct investments, with biotech about 20% of deals, including LifeMine Therapeutics’ $188 million Series E backed by Bezos Expeditions and Gates Frontier. Duquesne Family Office also backed Epicrispr Biotechnologies at a $90 million Series C. The moves underscore AI’s growing role in biotech and a broader VC rebound, as biotech funding reached a multi-year high in H1 2026 (about $12.6 billion in the US and Europe), even as investors skew toward later-stage programs with drugs already in testing.

Thyme Care hits $2B valuation with $125M raise, forms Thyme Companies to tackle cancer care gaps
business1 month ago

Thyme Care hits $2B valuation with $125M raise, forms Thyme Companies to tackle cancer care gaps

Thyme Care raises $125 million in a Series E at a valuation above $2 billion and is creating a new parent company, Thyme Companies, to address cancer drug affordability and clinical-trial access. The platform serves 10.5 million people, manages $7 billion in oncology spend, and is profitable with positive free cash flow; leadership shifts place Brad Diephuis as CEO, with the first new Thyme Companies initiative launching later this year.